• Welcome
    Sponsors
  • Director
    Members
    Advisory Board
    International Advisory Council
    Research Affiliates
    IPilogue Editors
  • IPilogue
    Events
    Publications
  • JD
    Graduate Program
    Clinical
    Prizes & Awards
  • The IPIGRAM Archive
    Events Archive
    IP in the News
    IP Poll of the Week
    IP Pick of the Week
    Gowlings IPilogue Prize
  • Legislation
    Journals
    Government
  • Contact Us
    Subscribe

Public Interest Litigation to Prevent GM Seeds in India

July 27, 2009 by Jasdeep Bal

Jasdeep Bal is a JD candidate at Osgoode Hall Law School.

The Human Rights Law Network (where I am summer interning) utilizes public interest litigation (PIL) as their primary weapon to fight for human rights. The People’s Patent Group, under the umbrella of HRLN, is not a priority, however, as HRLN seems to have their hands full at the moment with securing maternal rights, rights for HIV/AIDS positive people, dalit rights, and right to food and healthcare, to name a few initiatives. As a result, issues involving GM seeds are not actively fought. As a matter of fact, I have not met a single person working for the People’s Patent Group, aside from Nigel D’Souza, my colleague-intern from Osgoode. HRLN therefore expects the interns to devise their own research proposal and submit a deliverable that will (hopefully) be useful to HRLN in furthering a PIL.

My area of interest was GM seed patents and the social, economic, and legal issues created by such patents. To focus on a project that would be useful to HRLN, I began by reading and analyzing a PIL on the biosafety of GMOs that was filed in the Supreme Court of India in 2005. Several issues came to light in this petition. Firstly, I noticed that very little scientific background was provided. As the name implies, GMOs are genetically altered organisms that are engineered to enhance a certain genetic trait (or to suppress a trait). For thousands of years, traditional farmers have been ‘genetically manipulating’ their seeds without actually knowing it, by planting certain seeds and discarding others. The process of freely trading and planting seeds with other farmers has allowed for a genetic diversity that provides the farmer with the benefit of a strong crop.

Today, companies like Monsanto are able to modify the genes of seed varieties in a way that is much less subtle than the traditional farmers freely trading and planting seeds over generations. Without any scientific explanation, the PIL stated that these GM seeds are deemed hazardous to the environment and to people by scientists across the board (neither does the PIL source their information or name scientists…). Furthermore, the PIL seemed to confuse or blur the issue by stating that the GM safety standards, although good, are not properly applied and many GM products that would otherwise fail are deemed safe to eat (this argument seems to imply that if GM safety standards are applied adequately, then GM seeds would be safe to eat?).

Thus, my experience at HRLN in my first few weeks made me aware of the following: First, that the PPG is virtually nonexistent at the moment and that my research needs to be useful to the PPG in initiating a future PIL; and secondly, that any information in a PIL needs to be sourced; and third, that it is important to separate and compartmentalize the legal issues for simplicity sake. After discussing with Colin Gonsalves, the head advocate at HRLN, I decided that my goal with the PPG will be to produce a short internal document that will serve to educate the lawyers (briefly) on the issues surrounding GMOs as well as emphasizing the need to adequately source and provide the legal issues at hand when filing a PIL. The hope from my end is that my work here will be useful, if even in a small way, in creating a PIL in the near future.

Posted in Human Rights Issues, Patents

Leave a Reply

All replies and responses are moderated and will not appear on the site immediately. Please see our response policy.

« A Report about Facebook by the Office of the Privacy Commissioner of Canada | Patent Prosecution as Part of Business Models? »

Career Opportunities
Osgoode IP Club
Writing Competitions
IP Research Guide

RSS Follow Comments via RSS
  • James Wagner on Copyright at the Edge of Artistic Creativity
  • Ken Anderson on Bill C-11: Through the Lens of Social Norms
  • Courtney Doagoo on Evidence Of Parasitic Intent Not Unfounded: L’Oreal
  • Denis Borges Barbosa on Evidence Of Parasitic Intent Not Unfounded: L’Oreal
  • D Vaver on Disclosure Front and Centre as Pfizer Prepares to Defend Viagra in Supreme Court of Canada
  • Dr. Emir Crowne on Disclosure Front and Centre as Pfizer Prepares to Defend Viagra in Supreme Court of Canada
  • Adam Stevenson on Bill C-11: Through the Lens of Social Norms
  • Anonymous on Should Canada Strengthen IP Protection for Pharmaceutical Products? The European Union Thinks So...
  • Aidan Hollis on Should Canada Strengthen IP Protection for Pharmaceutical Products? The European Union Thinks So...
  • Kalen Lumsden on IP Osgoode Speaker Series: Robert Levine and Dr. Brett Danaher
RSS Follow Posts via RSS
  • One Step Closer: Bill C-11
  • Bergeron Entrepreneurs in Science and Technology (BEST) Program Launches at York
  • Whose Patent is It Anyway?: The Ongoing Legal Legacy Between Samsung and Apple
  • Copyright at the Edge of Artistic Creativity
  • Luksan v. Van der Let, Or Rather, EU v. UrhG?
  • Global Health Challenges and the Role of Law
  • Sampling Questions Still Unsettled After Jay-Z/Kanye West Sampling Settlement
  • World Intellectual Property Day 2012
  • The Legal Implications of Commercializing Intellectual Property Rights
  • Announcement: Global Health Challenges and the Role of Law: the 2012 National Health Law Conference

IP Osgoode would like to send out its IPIGRAM at a time when most convenient for you. Please let us know your views by answering a few questions so that we can better serve you.

Click here to take poll.
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • June 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • November 2007
  • October 2007
  • Advisory Board (4)
  • Announcements (2)
  • Blogs (4)
  • Book Review (3)
  • Broadcasting Regulatory Policy (5)
  • Cloud Services (3)
  • Commercialization (77)
  • Competition (6)
  • Competition Law (7)
  • Contracts (59)
  • copyright reform (136)
  • defamation (15)
  • Design (6)
  • Development (4)
  • European Union (32)
  • events (75)
  • Fashion Industry (13)
  • Feature Post (126)
  • Freedom of Speech (15)
  • Freedom of the Press (14)
  • Gaming (6)
  • General (145)
  • Human Rights (3)
  • Image (2)
  • Innovation (138)
  • Internet (236)
  • IP (1041)
    • Copyright (522)
      • CD Levy (9)
      • Digital Downloads (64)
      • Digital Libraries (1)
      • Digital Locks (28)
      • Fair Dealing (61)
        • Parody (2)
        • Satire (1)
      • Infringement (124)
      • Internet Sharing (92)
      • Literary Works (52)
      • Moral Rights (9)
      • Movies (47)
      • Music Industry (88)
      • Originality (29)
      • Ownership (81)
        • Licensees (31)
      • Secondary (ISP) Liability (14)
      • Subsidiary Rights (5)
    • IP Reform (19)
    • Patents (331)
      • Access to Medicines (12)
      • Cross Border Issues (48)
      • Electronic Processes (18)
      • Infringement (60)
      • Patent Practice (18)
      • Patent Trolls (20)
      • Patentability (97)
      • Pharmaceutical Drugs (65)
    • Trademarks (201)
      • Domain Names (38)
      • Famous Marks (15)
      • Official Marks (10)
      • Parallel Importation (4)
      • Personality Rights (11)
  • IP Course Topic (11)
  • IP Intensive (4)
  • IP Litigation Practice (15)
  • Jurisdiction (65)
    • Canada (24)
    • Indonesia (1)
    • Japan (1)
    • UK (25)
    • US (28)
  • Law & Music Course Topic (20)
  • Links (3)
  • MediaLaws (6)
  • Music Industry (72)
  • Open-Source (16)
  • Osgoode Alumnus (10)
  • Patents Course Topic (28)
  • Privacy (165)
    • Electronic Databases (36)
    • Human Rights Issues (26)
    • Identity Theft (11)
  • Regulatory Policy (46)
  • Reputation Management (2)
  • Smartphones (10)
  • Social Justice (2)
    • United Nations Development Programme (1)
  • Social Media (23)
  • Supreme Court of Canada (17)
  • Tech Transfer (29)
  • Technology (208)
  • Telecommunications (73)
  • Trade Secrets (3)
  • UK (10)
  • Uncategorized (82)
  • US-Canada Relations (2)
  • WIPO (9)
  • Log in

Home   |   Contact Us  

© 2008 Osgoode Hall Law School York University
4700 Keele Street Toronto, Canada M3J 1P3
T:416.736.5030   F:416.736.5736